Cronos Group (CRON) vs Harrow (HROW)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cronos Group (CRON) has outperformed Harrow (HROW) over the past year, gaining 23.7% versus a loss of 26.9%. Over five years, HROW leads with a +209.6% price change compared with -40.9% for CRON. Cronos Group is the larger company by market cap ($1.17 billion vs $1.15 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CRON | HROW |
|---|---|---|
| Share price | $3.18 | $30.57 |
| Market cap | $1.17B | $1.15B |
| 1-day change | -2.01% | -0.16% |
| YTD return | +23.19% | -37.51% |
| 1-year return | +23.66% | -26.92% |
| 5-year return | -40.88% | +209.61% |
| P/E ratio (TTM) | 16.71 | — |
| Forward P/E | — | 11.03 |
| EPS (TTM) | $0.19 | $-0.99 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.61 | $54.85 |
| 52-week low | $2.28 | $28.54 |
| Distance from 52-week high | -12.00% | -44.27% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | -22.52% | +112.63% |
| Average volume | 1.13M | 555.14K |
| Shares outstanding | 368.41M | 37.49M |
| Employees | 610 | 373 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CRON has outperformed HROW by 50.6 percentage points over the past year.
About Cronos Group
CRON stock →Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names.
Health Care · Medicinal Chemicals and Botanical Products · 610 employees
About Harrow
HROW stock →Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments.
Health Care · Biotechnology: Pharmaceutical Preparations · 373 employees
CRON vs HROW FAQ
Which is bigger, Cronos Group or Harrow?
Cronos Group (CRON) is larger, with a market capitalization of $1.17B compared with $1.15B for Harrow (HROW).
Which stock has performed better over the past year, CRON or HROW?
CRON returned +23.66% over the past 12 months, compared with -26.92% for HROW (price return, excluding dividends). Past performance does not predict future results.
Are Cronos Group and Harrow in the same industry?
Both are in the Health Care sector, but in different industries: Medicinal Chemicals and Botanical Products for Cronos Group and Biotechnology: Pharmaceutical Preparations for Harrow.